Cormorant Asset Management as of Dec. 31, 2021
Portfolio Holdings for Cormorant Asset Management
Cormorant Asset Management holds 78 positions in its portfolio as reported in the December 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Erasca (ERAS) | 9.7 | $164M | 11M | 15.58 | |
Turning Point Therapeutics I | 8.6 | $144M | 3.0M | 47.70 | |
Design Therapeutics (DSGN) | 6.9 | $117M | 5.4M | 21.41 | |
Prometheus Biosciences | 4.3 | $73M | 1.8M | 39.54 | |
Forma Therapeutics Hldgs SHS | 3.9 | $66M | 4.6M | 14.22 | |
Monte Rosa Therapeutics (GLUE) | 3.6 | $61M | 3.0M | 20.42 | |
Revolution Medicines (RVMD) | 3.6 | $61M | 2.4M | 25.17 | |
Edgewise Therapeutics (EWTX) | 3.2 | $55M | 3.6M | 15.28 | |
Tango Therapeutics (TNGX) | 3.2 | $53M | 4.9M | 10.85 | |
Avidity Biosciences Ord (RNA) | 2.8 | $48M | 2.0M | 23.77 | |
Verve Therapeutics (VERV) | 2.4 | $41M | 1.1M | 36.87 | |
Beam Therapeutics (BEAM) | 2.4 | $40M | 500k | 79.69 | |
Immuneering Corp Class A Com (IMRX) | 2.2 | $37M | 2.3M | 16.17 | |
Bioatla (BCAB) | 2.0 | $33M | 1.7M | 19.63 | |
Cytokinetics Com New (CYTK) | 1.9 | $32M | 700k | 45.58 | |
Tarsus Pharmaceuticals (TARS) | 1.9 | $32M | 1.4M | 22.50 | |
Rain Therapeutics | 1.8 | $30M | 2.3M | 12.88 | |
Apellis Pharmaceuticals (APLS) | 1.8 | $30M | 625k | 47.28 | |
Stoke Therapeutics (STOK) | 1.7 | $28M | 1.2M | 23.99 | |
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.7 | $28M | 2.5M | 11.26 | |
Bridgebio Pharma (BBIO) | 1.7 | $28M | 1.7M | 16.68 | |
Biomea Fusion (BMEA) | 1.4 | $24M | 3.2M | 7.45 | |
Ambrx Biopharma Sponsored Ads | 1.3 | $23M | 2.5M | 9.03 | |
Aerovate Therapeutics (AVTE) | 1.3 | $22M | 1.8M | 11.79 | |
Olema Pharmaceuticals (OLMA) | 1.2 | $20M | 2.2M | 9.36 | |
Rocket Pharmaceuticals (RCKT) | 1.1 | $19M | 869k | 21.83 | |
Talaris Therapeutics | 1.1 | $18M | 1.2M | 15.29 | |
Axonics Modulation Technolog (AXNX) | 1.1 | $18M | 322k | 56.00 | |
Alx Oncology Hldgs (ALXO) | 1.0 | $16M | 762k | 21.49 | |
Ventyx Biosciences (VTYX) | 0.9 | $15M | 785k | 19.26 | |
Atea Pharmaceuticals (AVIR) | 0.9 | $15M | 1.7M | 8.94 | |
Praxis Precision Medicines I | 0.9 | $15M | 752k | 19.70 | |
Igm Biosciences (IGMS) | 0.9 | $15M | 500k | 29.33 | |
Chemocentryx | 0.9 | $15M | 400k | 36.41 | |
Gh Research Ordinary Shares (GHRS) | 0.8 | $14M | 608k | 23.33 | |
Adicet Bio (ACET) | 0.8 | $13M | 750k | 17.49 | |
Aclaris Therapeutics (ACRS) | 0.8 | $13M | 900k | 14.54 | |
Elevation Oncology (ELEV) | 0.7 | $12M | 2.0M | 6.02 | |
Tyra Biosciences (TYRA) | 0.7 | $12M | 840k | 13.82 | |
Longboard Pharmaceuticals In (LBPH) | 0.7 | $11M | 2.3M | 4.87 | |
Mirati Therapeutics | 0.7 | $11M | 75k | 146.69 | |
Vectivbio Hldg Ord Shs | 0.6 | $11M | 2.2M | 4.91 | |
Pharvaris N V (PHVS) | 0.6 | $9.9M | 690k | 14.39 | |
Zymeworks | 0.6 | $9.8M | 600k | 16.39 | |
Icosavax | 0.6 | $9.8M | 426k | 22.88 | |
Keros Therapeutics (KROS) | 0.5 | $8.8M | 150k | 58.51 | |
Akero Therapeutics (AKRO) | 0.5 | $8.5M | 404k | 21.15 | |
Pyxis Oncology Common Stock (PYXS) | 0.4 | $7.1M | 669k | 10.64 | |
Iteos Therapeutics (ITOS) | 0.4 | $7.0M | 150k | 46.56 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 0.4 | $6.7M | 50k | 134.52 | |
Pliant Therapeutics (PLRX) | 0.4 | $6.5M | 482k | 13.50 | |
Aligos Therapeutics (ALGS) | 0.4 | $6.2M | 521k | 11.87 | |
Miragen Therapeutics (VRDN) | 0.4 | $5.9M | 300k | 19.77 | |
Eledon Pharmaceuticals (ELDN) | 0.3 | $5.8M | 1.3M | 4.41 | |
Y Mabs Therapeutics (YMAB) | 0.3 | $4.9M | 300k | 16.21 | |
Cabaletta Bio (CABA) | 0.3 | $4.4M | 1.2M | 3.79 | |
Helix Acquisition Corp Com Cl A | 0.3 | $4.3M | 430k | 9.89 | |
Harpoon Therapeutics | 0.2 | $4.1M | 541k | 7.55 | |
Celldex Therapeutics Com New (CLDX) | 0.2 | $3.9M | 100k | 38.64 | |
Renovacor | 0.2 | $3.9M | 500k | 7.70 | |
Meiragtx Holdings (MGTX) | 0.2 | $3.6M | 150k | 23.74 | |
Anaptysbio Inc Common (ANAB) | 0.2 | $3.5M | 100k | 34.75 | |
Akouos | 0.2 | $3.4M | 395k | 8.50 | |
Merus N V (MRUS) | 0.2 | $3.2M | 100k | 31.80 | |
Galecto (GLTO) | 0.2 | $3.1M | 1.0M | 3.03 | |
Astria Therapeutics (ATXS) | 0.2 | $3.0M | 553k | 5.39 | |
Precision Biosciences Ord | 0.2 | $2.6M | 347k | 7.40 | |
Graphite Bio | 0.2 | $2.5M | 203k | 12.43 | |
Gossamer Bio (GOSS) | 0.1 | $2.2M | 198k | 11.31 | |
Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $2.0M | 392k | 5.19 | |
Uniqure Nv SHS (QURE) | 0.1 | $1.0M | 50k | 20.74 | |
Connect Biopharma Hldgs Ads (CNTB) | 0.1 | $1.0M | 200k | 5.15 | |
Sonendo (SONX) | 0.1 | $859k | 149k | 5.76 | |
Atreca Cl A Com (BCEL) | 0.0 | $829k | 274k | 3.03 | |
Orchard Therapeutics Ads | 0.0 | $339k | 257k | 1.32 | |
Imv | 0.0 | $289k | 234k | 1.23 | |
X4 Pharmaceuticals (XFOR) | 0.0 | $238k | 104k | 2.29 | |
Outlook Therapeutics *w Exp 02/18/202 | 0.0 | $32k | 271k | 0.12 |